Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model.

Evaluation of the efficacy of modified vaccinia Ankara (MVA)/IMVAMUNE against aerosolized rabbitpox virus in a rabbit model.
复制标题

DOI:
10.1016/j.vaccine.2009.06.105
复制
发表时间:
2009-09-04
期刊:
影响因子:
5.5
通讯作者:
Nalca A
Nalca A
中科院分区:
医学3区
文献类型:
--
作者:
Garza NL;Hatkin JM;Livingston V;Nichols DK;Chaplin PJ;Volkmann A;Fisher D;Nalca A

文献摘要

参考文献

被引文献

相似文献

Infection of rabbits with aerosolized rabbitpox virus (RPXV) produces a disease similar to monkeypox and smallpox in humans and provides a valuable, informative model system to test medical countermeasures against orthopoxviruses. Due to the eradication of smallpox, the evaluation of the efficacy of new-generation smallpox vaccines depends on relevant well-developed animal studies for vaccine licensure. In this study, we tested the efficacy of IMVAMUNE® [modified vaccinia Ankara-Bavarian Nordic (MVA-BN®)] for protecting rabbits against aerosolized RPXV. Rabbits were vaccinated with either phosphate-buffered saline (PBS), Dryvax®, a single low dose of IMVAMUNE®, a single high dose of IMVAMUNE®, or twice with a high dose of IMVAMUNE®. Aerosol challenge with a lethal dose of RPXV was performed 4 weeks after the last vaccination. All PBS control animals succumbed to the disease or were euthanized because of the disease within 7 days postexposure. The rabbits vaccinated with Dryvax®, a low dose of IMVAMUNE®, or a single high dose of IMVAMUNE® showed minimal to moderate clinical signs of the disease, but all survived the challenge. The only clinical sign displayed by rabbits that had been vaccinated twice with a high dose of IMVAMUNE® was mild transient anorexia in just two out of eight rabbits. This study shows that IMVAMUNE® can be a very effective vaccine against aerosolized RPXV.
DOI: 10.1128/jvi.01706-07
发表时间: 2008-01-01
影响因子: 5.4
作者:
Davies, D. Huw;Wyatt, Linda S.;Felgner, Philip L.
通讯作者: Felgner, Philip L.
DOI: 10.1172/jci33940
发表时间: 2008-05-01
影响因子: 15.9
作者:
Samuelsson, Christofer;Hausmann, Juergen;Hochrein, Hubertus
通讯作者: Hochrein, Hubertus
DOI: 10.1128/jvi.00423-07
发表时间: 2007-10-01
影响因子: 5.4
作者:
Adams, Mathew M.;Rice, Amanda D.;Moyer, R. W.
通讯作者: Moyer, R. W.
DOI: 10.1016/j.vaccine.2007.10.017
发表时间: 2007-12-12
期刊: VACCINE
影响因子: 5.5
作者:
Frey, Sharon E.;Newman, Frances K.;Belshe, Robert B.
通讯作者: Belshe, Robert B.
DOI: 10.1086/513968
发表时间: 1997-04-01
影响因子: 6.4
作者:
McClain, DJ;Harrison, S;Graham, JA
通讯作者: Graham, JA